Close Menu

NEW YORK – Diagnostics firm Oncocyte is anticipating a significant expansion of its clinical and research-use testing footprint this year following yet another acquisition — the company's third in less than two years.

The firm said in February that it had agreed to acquire German diagnostics firm Chronix Biomedical with the deal superseding a previously announced collaboration between the companies.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.